Impact of Peginterferon Alpha and Ribavirin Treatment on Lipid Profiles and Insulin Resistance in Hepatitis C Virus/HIV–Coinfected Persons: The AIDS Clinical Trials Group A5178 Study

Background. The effect of peginterferon alpha/ribavirin (PEG-IFN/RBV) and hepatitis C virus (HCV) clearance on lipid and insulin resistance (IR) profiles in HCV/human immunodeficiency virus (HIV) coinfection is unknown. Methods. We measured fasting total cholesterol (TC), low-density lipoprotein (LD...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Butt, Adeel A., Umbleja, Triin, Andersen, Janet W., Sherman, Kenneth E., Chung, Raymond T.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2012
Gaiak:
Articles and Commentaries
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3491848/
https://ncbi.nlm.nih.gov/pubmed/22563020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cis463
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak